Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

Published:2010-02-25 Issue:3 Volume:62 Page:845-854
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

O'Neill Sean G.,Giles Ian,Lambrianides Anastasia,Manson Jessica,D'Cruz David,Schrieber Leslie,March Lyn M.,Latchman David S.,Isenberg David A.,Rahman Anisur

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.27286/fullpdf

Reference37 articles.

1. Mortality in systemic lupus erythematosus;Bernatsky;Arthritis Rheum,2006

2. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study;Manzi;Am J Epidemiol,1997

3. The role of preventive cardiology in systemic lupus erythematosus;Elliott;Curr Rheumatol Rep,2007

4. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus;Esdaile;Arthritis Rheum,2001

5. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus;Bessant;Rheumatology (Oxford),2004

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Other autoantibodies;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity;International Immunopharmacology;2024-09

3. Associations of HDL-C and ApoA-I with Mortality Risk in PCI Patients Across Different hsCRP Levels;Journal of Inflammation Research;2024-07

4. A method for detection of anti-drug antibodies to a biotherapeutic (CSL112) with endogenous counterpart (apolipoprotein A-I) using a novel sample pre-treatment electrochemiluminescence assay;Journal of Immunological Methods;2023-02

5. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages;Rheumatology;2023-01-06